Pharmaceuticals Cohort study compares weight loss effects of tirzepatide and semaglutide Last updated: July 13, 2024 1:31 pm By bexib 0 Min Read Share SHARE The JAMA study aimed to determine how weight loss differs between patients receiving tirzepatide and those receiving semaglutide in a clinical population of overweight adults. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Credit Card Float: What It Is & How To Avoid It (2024) Next Article Super fast, super smart: Haas and Phillips machine tools bring about a new era in Indian manufacturing Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Top 5 Open Banking Stories of 2024 Banking Ecommerce SEO Pros on AI, Strategies for 2025 Retail & E-commerce Brintons launches first commercial carpet collection with V&A Hospitality & Tourism Editor’s Pick: Top 3 Features of 2024 Banking